Corteva, Inc. (NYSE:CTVA) Shares Sold by Mather Group LLC.

Mather Group LLC. reduced its position in Corteva, Inc. (NYSE:CTVA) by 4.4% in the 4th quarter, HoldingsChannel.com reports. The fund owned 12,209 shares of the company’s stock after selling 560 shares during the quarter. Mather Group LLC.’s holdings in Corteva were worth $585,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. CVA Family Office LLC acquired a new position in shares of Corteva during the fourth quarter worth about $25,000. NewSquare Capital LLC boosted its holdings in Corteva by 70.6% in the third quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock valued at $28,000 after purchasing an additional 226 shares in the last quarter. Glass Jacobson Investment Advisors llc boosted its holdings in Corteva by 234.3% in the third quarter. Glass Jacobson Investment Advisors llc now owns 555 shares of the company’s stock valued at $28,000 after purchasing an additional 389 shares in the last quarter. BKM Wealth Management LLC acquired a new position in Corteva in the fourth quarter valued at approximately $27,000. Finally, Union Savings Bank boosted its holdings in Corteva by 58.5% in the third quarter. Union Savings Bank now owns 577 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares in the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Trading Down 0.4 %

NYSE:CTVA opened at $53.90 on Thursday. The stock has a fifty day moving average price of $55.28 and a two-hundred day moving average price of $50.56. The stock has a market capitalization of $37.67 billion, a price-to-earnings ratio of 52.84, a PEG ratio of 1.45 and a beta of 0.77. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.90 and a current ratio of 1.56. Corteva, Inc. has a 1 year low of $43.22 and a 1 year high of $61.07.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.09. The firm had revenue of $3.71 billion during the quarter, compared to analysts’ expectations of $3.54 billion. Corteva had a return on equity of 7.43% and a net margin of 4.27%. During the same quarter in the prior year, the business posted $0.16 earnings per share. As a group, sell-side analysts anticipate that Corteva, Inc. will post 2.84 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Shareholders of record on Tuesday, June 4th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 1.19%. The ex-dividend date is Tuesday, June 4th. Corteva’s dividend payout ratio (DPR) is 62.75%.

Analyst Ratings Changes

A number of brokerages recently issued reports on CTVA. Wells Fargo & Company upped their price target on Corteva from $54.00 to $65.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. UBS Group lowered their price target on Corteva from $65.00 to $64.00 and set a “buy” rating for the company in a report on Thursday, January 11th. BNP Paribas raised Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 price target for the company in a report on Friday, February 2nd. Oppenheimer boosted their price objective on Corteva from $62.00 to $67.00 and gave the company an “outperform” rating in a research note on Tuesday, April 16th. Finally, Wolfe Research began coverage on Corteva in a research note on Friday, March 1st. They issued an “outperform” rating and a $67.00 price objective for the company. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Corteva has an average rating of “Moderate Buy” and a consensus price target of $63.29.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.